nox2 Search Results


94
Proteintech nox2
Nox2, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/10__1016_slash_j__gendis__2026__102102-108-62-64?v=Proteintech
Average 94 stars, based on 1 article reviews
nox2 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

96
Proteintech anti nox2
Anti Nox2, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pm41861539-104-41-43?v=Proteintech
Average 96 stars, based on 1 article reviews
anti nox2 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

94
Novus Biologicals monoclonal mouse anti nox2
Monoclonal Mouse Anti Nox2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pm35158782-50-42-47?v=Novus+Biologicals
Average 94 stars, based on 1 article reviews
monoclonal mouse anti nox2 - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier

93
Novus Biologicals cybb
Cybb, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/bio_rxiv__2023__12__04__570023-286-41-42?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
cybb - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

93
Novus Biologicals nox2 nbp2 41291 rabbit polyclonal novus biologicals
Nox2 Nbp2 41291 Rabbit Polyclonal Novus Biologicals, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/ppr0882748-157-8-12?v=Novus+Biologicals
Average 93 stars, based on 1 article reviews
nox2 nbp2 41291 rabbit polyclonal novus biologicals - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

91
Novus Biologicals nox2 antibody
( A and B ) The production of superoxide was determined in HAECs. HAECs were infected with Ad- lacZ or Ad- KLF11 , or Ad-sh lacZ or Ad-sh KLF11 (10 MOI). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution (fluorescent probes). ( C – E ) HAECs were infected with Ad- GFP or Ad- KLF11 (10 MOI) or transfected with control siRNA (siControl) or KLF11 siRNA (si KLF11 , 20 μM). After 48 hours, they were stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 24 hours. ( C and D ) The mRNA levels of NOX1 , <t>NOX2</t> , NOX4 , and NOX5 were determined by qPCR. ( E ) Western blot to determine the expression of NOX2 in HAECs. ( F ) HAECs were transfected with siControl, si KLF11 or si KLF11 + NOX2 siRNA (si NOX2 ) (20 μM). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution. ( G and H ) Representative DHE staining and quantification of superoxide production in HAECs. HAECs were transfected with siControl, si KLF11 , or si KLF11 +si NOX2 . After 48 hours, they were pretreated with NOX2 inhibitor (NOX2i, GSK2795039, 1 μM) for 1 hour, then stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours, followed by DHE staining of superoxide (red) and immunofluorescence staining of VE-cadherin (green). Nuclei stained by DAPI are shown in blue. Scale bar: 20 μm. ( I ) HAECs were infected with Ad- lacZ or Ad-flag- KLF11 . After 48 hours, they were stimulated with TNF-α (2 ng/mL) for 4 hours, followed by ChIP assay using an antibody against flag or IgG. Data are presented as mean ± SEM. Two-way ANOVA followed by Holm-Sidak post hoc analysis ( A – D , F , H , and I ).
Nox2 Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pmc08021107-175-0-6?v=Novus+Biologicals
Average 91 stars, based on 1 article reviews
nox2 antibody - by Bioz Stars, 2026-08
91/100 stars
  Buy from Supplier

90
OriGene human nox2
The levels of <t>NOX2</t> are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.
Human Nox2, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pmc08833670-78-3-27?v=OriGene
Average 90 stars, based on 1 article reviews
human nox2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Novus Biologicals nox2
The levels of <t>NOX2</t> are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.
Nox2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pm32979061-75-34-38?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
nox2 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
OriGene myc ddk
The levels of <t>NOX2</t> are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.
Myc Ddk, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pmc03859815-51-0-10?v=OriGene
Average 90 stars, based on 1 article reviews
myc ddk - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

90
Novus Biologicals anti cybb nox2 pe ab
The levels of <t>NOX2</t> are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.
Anti Cybb Nox2 Pe Ab, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pmc05843401-75-0-4?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
anti cybb nox2 pe ab - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

85
Rockland Immunochemicals rabbit anti nox2
The levels of <t>NOX2</t> are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.
Rabbit Anti Nox2, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/nox2/pmc05138194-113-6-40?v=Rockland+Immunochemicals
Average 85 stars, based on 1 article reviews
rabbit anti nox2 - by Bioz Stars, 2026-08
85/100 stars
  Buy from Supplier

Image Search Results


( A and B ) The production of superoxide was determined in HAECs. HAECs were infected with Ad- lacZ or Ad- KLF11 , or Ad-sh lacZ or Ad-sh KLF11 (10 MOI). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution (fluorescent probes). ( C – E ) HAECs were infected with Ad- GFP or Ad- KLF11 (10 MOI) or transfected with control siRNA (siControl) or KLF11 siRNA (si KLF11 , 20 μM). After 48 hours, they were stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 24 hours. ( C and D ) The mRNA levels of NOX1 , NOX2 , NOX4 , and NOX5 were determined by qPCR. ( E ) Western blot to determine the expression of NOX2 in HAECs. ( F ) HAECs were transfected with siControl, si KLF11 or si KLF11 + NOX2 siRNA (si NOX2 ) (20 μM). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution. ( G and H ) Representative DHE staining and quantification of superoxide production in HAECs. HAECs were transfected with siControl, si KLF11 , or si KLF11 +si NOX2 . After 48 hours, they were pretreated with NOX2 inhibitor (NOX2i, GSK2795039, 1 μM) for 1 hour, then stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours, followed by DHE staining of superoxide (red) and immunofluorescence staining of VE-cadherin (green). Nuclei stained by DAPI are shown in blue. Scale bar: 20 μm. ( I ) HAECs were infected with Ad- lacZ or Ad-flag- KLF11 . After 48 hours, they were stimulated with TNF-α (2 ng/mL) for 4 hours, followed by ChIP assay using an antibody against flag or IgG. Data are presented as mean ± SEM. Two-way ANOVA followed by Holm-Sidak post hoc analysis ( A – D , F , H , and I ).

Journal: JCI Insight

Article Title: KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction

doi: 10.1172/jci.insight.141673

Figure Lengend Snippet: ( A and B ) The production of superoxide was determined in HAECs. HAECs were infected with Ad- lacZ or Ad- KLF11 , or Ad-sh lacZ or Ad-sh KLF11 (10 MOI). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution (fluorescent probes). ( C – E ) HAECs were infected with Ad- GFP or Ad- KLF11 (10 MOI) or transfected with control siRNA (siControl) or KLF11 siRNA (si KLF11 , 20 μM). After 48 hours, they were stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 24 hours. ( C and D ) The mRNA levels of NOX1 , NOX2 , NOX4 , and NOX5 were determined by qPCR. ( E ) Western blot to determine the expression of NOX2 in HAECs. ( F ) HAECs were transfected with siControl, si KLF11 or si KLF11 + NOX2 siRNA (si NOX2 ) (20 μM). After 48 hours, they were treated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours in the presence of superoxide detection solution. ( G and H ) Representative DHE staining and quantification of superoxide production in HAECs. HAECs were transfected with siControl, si KLF11 , or si KLF11 +si NOX2 . After 48 hours, they were pretreated with NOX2 inhibitor (NOX2i, GSK2795039, 1 μM) for 1 hour, then stimulated with TNF-α (2 ng/mL) or AngII (1 μM) for 2 hours, followed by DHE staining of superoxide (red) and immunofluorescence staining of VE-cadherin (green). Nuclei stained by DAPI are shown in blue. Scale bar: 20 μm. ( I ) HAECs were infected with Ad- lacZ or Ad-flag- KLF11 . After 48 hours, they were stimulated with TNF-α (2 ng/mL) for 4 hours, followed by ChIP assay using an antibody against flag or IgG. Data are presented as mean ± SEM. Two-way ANOVA followed by Holm-Sidak post hoc analysis ( A – D , F , H , and I ).

Article Snippet: NOX2 antibody (NBP2-67680) was purchased from Novus Biologicals.

Techniques: Infection, Transfection, Control, Western Blot, Expressing, Staining, Immunofluorescence

( A – E ) Human aortic smooth muscle cells (HASMCs) were treated for 24 hours with the conditioned media from ECs (EC-CM) that had been transfected with siControl, si KLF11 , or si KLF11 +si NOX2 (20 μM), or infected with Ad- GFP or Ad- KLF11 (10 MOI) and subsequently stimulated for 1 hour with TNF-α (2 ng/mL) 48 hours after siRNA transfection or adenovirus infection and cultured in fresh opti-MEM for an additional 4 hours. ( A – D ) qPCR ( A and C ) and Western blot ( B and D ) to examine expression of SMC-specific contractile markers (smooth muscle α-actin [SMA], calponin, and smooth muscle 22–α [SM22α]), proinflammatory cytokines (MCP-1 and IL-6), and metalloproteinases (MMP2 and MMP9). ( E ) HASMCs were cultured in EC-CM for 48 hours, followed by immunostaining of TUNEL. Scale bar: 20 μm. ( F – H ) Schematics of the in vitro coculture system using a Transwell. HAECs (upper chamber) transfected with siControl, si KLF11 (20 μM), or si KLF11 +si NOX2 or infected with Ad- GFP or Ad- KLF11 (10 MOI) were cultured for 48 hours followed by TNF-α (2 ng/mL) stimulation for 1 hour separately from HASMCs, changed to fresh opti-MEM, and then cocultured with HASMCs (bottom) in fresh opti-MEM for 24 hours. The expression of BAX in HASMCs was assayed by Western blot ( G and H ). Data are mean ± SEM from 3 independent experiments. Two-way ANOVA followed by Holm-Sidak post hoc analysis ( A , C , E , G , and H ).

Journal: JCI Insight

Article Title: KLF11 protects against abdominal aortic aneurysm through inhibition of endothelial cell dysfunction

doi: 10.1172/jci.insight.141673

Figure Lengend Snippet: ( A – E ) Human aortic smooth muscle cells (HASMCs) were treated for 24 hours with the conditioned media from ECs (EC-CM) that had been transfected with siControl, si KLF11 , or si KLF11 +si NOX2 (20 μM), or infected with Ad- GFP or Ad- KLF11 (10 MOI) and subsequently stimulated for 1 hour with TNF-α (2 ng/mL) 48 hours after siRNA transfection or adenovirus infection and cultured in fresh opti-MEM for an additional 4 hours. ( A – D ) qPCR ( A and C ) and Western blot ( B and D ) to examine expression of SMC-specific contractile markers (smooth muscle α-actin [SMA], calponin, and smooth muscle 22–α [SM22α]), proinflammatory cytokines (MCP-1 and IL-6), and metalloproteinases (MMP2 and MMP9). ( E ) HASMCs were cultured in EC-CM for 48 hours, followed by immunostaining of TUNEL. Scale bar: 20 μm. ( F – H ) Schematics of the in vitro coculture system using a Transwell. HAECs (upper chamber) transfected with siControl, si KLF11 (20 μM), or si KLF11 +si NOX2 or infected with Ad- GFP or Ad- KLF11 (10 MOI) were cultured for 48 hours followed by TNF-α (2 ng/mL) stimulation for 1 hour separately from HASMCs, changed to fresh opti-MEM, and then cocultured with HASMCs (bottom) in fresh opti-MEM for 24 hours. The expression of BAX in HASMCs was assayed by Western blot ( G and H ). Data are mean ± SEM from 3 independent experiments. Two-way ANOVA followed by Holm-Sidak post hoc analysis ( A , C , E , G , and H ).

Article Snippet: NOX2 antibody (NBP2-67680) was purchased from Novus Biologicals.

Techniques: Transfection, Infection, Cell Culture, Western Blot, Expressing, Immunostaining, TUNEL Assay, In Vitro

The levels of NOX2 are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: The levels of NOX2 are elevated in patients with GBM compared to low-grade glioma. ( a ) Representative immunofluorescence images of NOX2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (green), GFAP (red, glioma cells), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and GFAP-positive glioma cells. ( b , c ) Relative intensity of NOX2-positive staining ( b ) and quantification of NOX2 and GFAP-positive glioma cells ( c ) from ( a ). ( d ) The levels of NOX2 mRNA in patients with GBM and LGG dataset from TCGA. Wilcoxon test with two-sided and one-sided. ( e ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of NOX2 mRNA (n = 693) from GBM and LGG datasets from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Immunofluorescence, Staining, Two Tailed Test

NOX2 induces the activation of HK2-dependent glycolysis in human glioma cells. ( a ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( b ) quantification of ECAR levels in human glioma cells treated with NOX2 siRNA or control siRNA. ( c ) Representative immunoblot images and ( d ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells treated with NOX2 siRNA or control siRNA. β-actin was used as a loading control. ( e ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( f ) quantification of ECAR levels in human glioma cells with NOX2 over-expression or control. ( g ) Representative immunoblot images and ( h ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells with NOX2 over-expression or control. Β-actin was used as a loading control. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: NOX2 induces the activation of HK2-dependent glycolysis in human glioma cells. ( a ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( b ) quantification of ECAR levels in human glioma cells treated with NOX2 siRNA or control siRNA. ( c ) Representative immunoblot images and ( d ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells treated with NOX2 siRNA or control siRNA. β-actin was used as a loading control. ( e ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( f ) quantification of ECAR levels in human glioma cells with NOX2 over-expression or control. ( g ) Representative immunoblot images and ( h ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells with NOX2 over-expression or control. Β-actin was used as a loading control. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Activation Assay, Control, Western Blot, Over Expression, Two Tailed Test

Inhibition of NOX2 suppresses the activation of HK2-dependent glycolysis in human glioma cells. ( a ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( b ) quantification of ECAR levels in human glioma cells treated with GSK2795039 or DMSO. ( c ) Representative immunoblot images and ( d ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells treated with GSK2795039 or DMSO. β-actin was used as a loading control. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: Inhibition of NOX2 suppresses the activation of HK2-dependent glycolysis in human glioma cells. ( a ) The levels of extracellular acidification rate (ECAR) for glycolysis of glucose and ( b ) quantification of ECAR levels in human glioma cells treated with GSK2795039 or DMSO. ( c ) Representative immunoblot images and ( d ) quantification of NOX2, HK2, and LDH-A protein levels in human glioma cells treated with GSK2795039 or DMSO. β-actin was used as a loading control. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Inhibition, Activation Assay, Western Blot, Control, Two Tailed Test

High levels of NOX2 contribute to high levels of glucose uptake and HK2 expression in patients with GBM. ( a , b ) Representative 18 F-FDG PET /MRI images ( a ) and quantification of maximum TBR levels for 18 F-FDG uptake ( b ) in brains from patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1). ( c ) Representative immunofluorescence images of NOX2 and HK2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (red), HK2 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and HK2-positive cells. ( d , e ) Relative intensity of HK2-positive staining ( d ) and quantification of NOX2 and HK2-positive glioma cells ( e ) from ( c ). ( f ) The levels of HK2 mRNA in patients with GBM and LGG datasets from TCGA. Wilcoxon test with two-sided and one-sided. ( g ) Spearman’s correlation coefficient analysis between NOX2 and HK2 genes in patients (n = 693) with GBM and LGG dataset from TCGA. R = 0.63, p < 0.0001. ( h ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of HK2 mRNA (n = 693) from GBM and LGG dataset from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: High levels of NOX2 contribute to high levels of glucose uptake and HK2 expression in patients with GBM. ( a , b ) Representative 18 F-FDG PET /MRI images ( a ) and quantification of maximum TBR levels for 18 F-FDG uptake ( b ) in brains from patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1). ( c ) Representative immunofluorescence images of NOX2 and HK2 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (red), HK2 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and HK2-positive cells. ( d , e ) Relative intensity of HK2-positive staining ( d ) and quantification of NOX2 and HK2-positive glioma cells ( e ) from ( c ). ( f ) The levels of HK2 mRNA in patients with GBM and LGG datasets from TCGA. Wilcoxon test with two-sided and one-sided. ( g ) Spearman’s correlation coefficient analysis between NOX2 and HK2 genes in patients (n = 693) with GBM and LGG dataset from TCGA. R = 0.63, p < 0.0001. ( h ) The survival curve of patients with low (black) (n = 347) and high levels (red) (n = 346) of HK2 mRNA (n = 693) from GBM and LGG dataset from TCGA. The two groups were divided according to median value. p < 0.0001; Kaplan–Meier estimation test with two-sided and one-sided. The results are representative of three independent experiments and are shown as the mean ± SEM. *** p < 0.001, ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Expressing, Immunofluorescence, Staining, Two Tailed Test

NOX2 and HK2 induce COL5A1-mediated mesenchymal phenotype in human glioma cells. ( a ) The levels of COL5A1 and FN1 mRNA and ( b ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in human glioma cells treated with NOX2 siRNA or control siRNA. β-actin was used as a loading control. ( c ) The levels of COL5A1 and FN1 mRNA and ( d ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in human glioma cells with NOX2 over-expression (NOX2) or control (Control). β-actin was used as a loading control. ( e ) Representative images of cellular morphology in U87MG glioma cells with NOX2 over-expression (HK2) or control (Control) (left). Quantification of spindle shape length in U87MG glioma cells with NOX2 over-expression or control (right). Scale bars, 20 μm. ( f ) The levels of COL5A1 and FN1 mRNA and ( g ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in U87MG glioma cells with HK2 over-expression (HK2) or control (Control). ( h ) Representative images of cellular morphology in U87MG glioma cells with HK2 over-expression (HK2) or control (Control) (left). Scale bars, 20 μm. Quantification of spindle shape length in human glioma cells with HK2 over-expression (HK2) or control (Control) (right). The results are representative of three independent experiments and are shown as the mean ± SEM. * p < 0.05; Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: NOX2 and HK2 induce COL5A1-mediated mesenchymal phenotype in human glioma cells. ( a ) The levels of COL5A1 and FN1 mRNA and ( b ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in human glioma cells treated with NOX2 siRNA or control siRNA. β-actin was used as a loading control. ( c ) The levels of COL5A1 and FN1 mRNA and ( d ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in human glioma cells with NOX2 over-expression (NOX2) or control (Control). β-actin was used as a loading control. ( e ) Representative images of cellular morphology in U87MG glioma cells with NOX2 over-expression (HK2) or control (Control) (left). Quantification of spindle shape length in U87MG glioma cells with NOX2 over-expression or control (right). Scale bars, 20 μm. ( f ) The levels of COL5A1 and FN1 mRNA and ( g ) representative immunoblot images (left) and quantification (right) of COL5A1 and FN1 protein levels in U87MG glioma cells with HK2 over-expression (HK2) or control (Control). ( h ) Representative images of cellular morphology in U87MG glioma cells with HK2 over-expression (HK2) or control (Control) (left). Scale bars, 20 μm. Quantification of spindle shape length in human glioma cells with HK2 over-expression (HK2) or control (Control) (right). The results are representative of three independent experiments and are shown as the mean ± SEM. * p < 0.05; Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Western Blot, Control, Over Expression, Two Tailed Test

NOX2 and HK2 contributes to the gain of the COL5A1-mediated mesenchymal phenotype in patients with GBM. ( a ) Representative immunofluorescence images of NOX2 and COL5A1 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (red), COL5A1 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and COL5A1-positive cells. ( b ) Representative immunofluorescence images of HK2 and COL5A1 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing COL5A1 (red), HK2 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate HK2 and COL5A1-positive cells. ( c , d ) Relative intensity of COL5A1-positive staining ( c ) and quantification of NOX2 and COL5A1-positive glioma cells ( d ) from ( a ). ( e ) Quantification of HK2 and COL5A1-positive glioma cells from ( b ). ( f ) A Spearman’s correlation coefficient analysis between HK2 and COL5A1 gene patients (n = 693) with GBM and LGG datasets from TCGA. R = 0.28, p < 0.0001. ( g ) Spearman’s correlation coefficient analysis between HK2 and COL5A1 gene patients (n = 693) with GBM and LGG datasets from TCGA. R = 0.38, p < 0.0001. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Journal: Cancers

Article Title: NOX2-Induced High Glycolytic Activity Contributes to the Gain of COL5A1-Mediated Mesenchymal Phenotype in GBM

doi: 10.3390/cancers14030516

Figure Lengend Snippet: NOX2 and HK2 contributes to the gain of the COL5A1-mediated mesenchymal phenotype in patients with GBM. ( a ) Representative immunofluorescence images of NOX2 and COL5A1 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing NOX2 (red), COL5A1 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate NOX2 and COL5A1-positive cells. ( b ) Representative immunofluorescence images of HK2 and COL5A1 staining in patients with GBM (G4), G3 glioma (G3), G2 glioma (G2), and G1 glioma (G1) showing COL5A1 (red), HK2 (green), and DAPI-stained nuclei (blue) (n = 3 per group, n = 10 images per individual subject). Scale bars, 20 μm. White arrows indicate HK2 and COL5A1-positive cells. ( c , d ) Relative intensity of COL5A1-positive staining ( c ) and quantification of NOX2 and COL5A1-positive glioma cells ( d ) from ( a ). ( e ) Quantification of HK2 and COL5A1-positive glioma cells from ( b ). ( f ) A Spearman’s correlation coefficient analysis between HK2 and COL5A1 gene patients (n = 693) with GBM and LGG datasets from TCGA. R = 0.28, p < 0.0001. ( g ) Spearman’s correlation coefficient analysis between HK2 and COL5A1 gene patients (n = 693) with GBM and LGG datasets from TCGA. R = 0.38, p < 0.0001. The results are representative of three independent experiments and are shown as the mean ± SEM. ** p < 0.01, * p < 0.05; ANOVA or Student’s two-tailed t -test.

Article Snippet: For overexpression of human NOX2, U87MG cells were seeded (2 × 10 5 cells/6-well cell culture plates) and transfected with pCMV6-AC-GFP constructs containing human NOX2 (NM_000397) (RG207544, Origene, Rockville, MD, USA) or pCMV6-AC-GFP vector (PS100010, Origene) using lipofectamine LTX with Plus reagent (15338100, Thermo Fisher Scientific) according to the manufacturer’s instructions.

Techniques: Immunofluorescence, Staining, Two Tailed Test